Dr Reddy’s shares in focus after recall of mislabelled Levetiracetam injection in US
The potential risks include hypersensitivity reactions, liver injury, hematological toxicity, drowsiness, dizziness, ...
Medical Dialogues17h
CDSCO Panel Approves Updated Package Insert for Novartis' Ofatumumab Injection
Ofatumumab, a fully human anti-CD20 monoclonal antibody, is a disease-modifying therapy (DMT) approved for the treatment of ...
MyChesCo on MSN17h
Noramco Group Invests $25 Million to Expand Sterile Injectable Manufacturing
The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by ...
Dr. Reddy’s announces recall of Levetiracetam 0.75% Sodium Chloride injection
Laboratories announced that it is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1 ...
ConsumerAffairs3d
Dr. Reddy’s recalls levetiracetam infusion bags nationwide due to mislabeling
Dr. Reddy’s Laboratories has initiated a voluntary recall of Levetiracetam in 0.75% Sodium Chloride Injection (1,000 mg/100 ...
Multiple Sclerosis News Today3d
FDA approves prefilled syringe formulation of Ani’s Cortrophin Gel
The FDA approved a prefilled syringe format for Ani's purified Cortrophin Gel that should ease administration for MS patients ...
Center for Biosimilars3d
More Ustekinumab Biosimilars Join US Market Share Fight
Celltrion and Formycon with Fresenius Kabi launched their respective ustekinumab biosimilars (Steqeyma and Otulfi), joining 4 ...
Dr. Reddy’s recalls Levetiracetam Sodium Chloride Injection in US market
Dr Reddy’s Laboratories is recalling one batch of Levetiracetam in 0.75 percent Sodium Chloride Injection single-dose ...
Dr. Reddy’s recalls mislabelled seizure injection Levetiracetam in U.S. to consumer level
Dr. Reddy's recalls Levetiracetam infusion bags in the U.S. due to mislabeling, posing risk of serious adverse effects.
Dr. Reddy's recalls Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL in US
Dr. Reddy's Laboratories is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level, in the ...
CNBCTV183d
Dr Reddy’s recalls epilepsy drug in US over mislabeling concerns
The mislabeling poses a significant health risk, as patients receiving the drug could inadvertently be administered double ...
Dr. Reddy’s recalls mislabelled Levetiracetam injection in the US; patients likely to experience 'adverse' events
Dr. Reddys Laboratories is recalling a batch of Levetiracetam injection bags in the U.S. due to incorrect labeling, which ...